BIOCEPT INC Quarterly Earnings Per Share, Basic in USD/shares from Q1 2013 to Q2 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Biocept Inc quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2013 to Q2 2023.
  • Biocept Inc Earnings Per Share, Basic for the quarter ending June 30, 2023 was -3.5 USD/shares, a 80.4% increase year-over-year.
  • Biocept Inc Earnings Per Share, Basic for the twelve months ending June 30, 2023 was 12.2 USD/shares.
  • Biocept Inc annual Earnings Per Share, Basic for 2022 was -1.89 USD/shares, a 895% decline from 2021.
  • Biocept Inc annual Earnings Per Share, Basic for 2021 was -0.19 USD/shares, a 87.3% increase from 2020.
  • Biocept Inc annual Earnings Per Share, Basic for 2020 was -1.5 USD/shares, a 87.7% increase from 2019.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $12.20 -$4 +$14.30 +80.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$2 $0 $0 -215% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 -$2 $16.70 +$16.90 Oct 1, 2022 Dec 31, 2022 10-K 2023-04-17
Q3 2022 -$19 -$1 -$1 -1400% Jul 1, 2022 Sep 30, 2022 10-Q/A 2023-04-17
Q2 2022 -$18 -$18 -$18 -12629% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$1 $0 $0 -168% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $0 $0 -$1 -145% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 $0.45 $0 +$0.33 +89.2% Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-04-17
Q2 2021 $0.12 $0 +$0.37 +72.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 $0 $0.19 +$1.25 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$2 $0.44 +$0.64 Oct 1, 2020 Dec 31, 2020 10-K 2022-04-05
Q3 2020 -$2 $0 +$2.10 +85% Jul 1, 2020 Sep 30, 2020 10-K 2022-04-05
Q2 2020 -$4 -$1 $0 -34.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$4 -$1 $0 -73.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$4 $0 +$1.23 +86% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-27
Q3 2019 -$5 -$2 $0 -2.07% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$5 $0 +$2.32 +85.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$7 -$1 +$2.72 +81.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$10 -$1 +$3.93 +73.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$14 -$2 +$3.43 +58.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-27
Q2 2018 -$17 -$3 +$3.62 +57.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-27
Q1 2018 -$21 -$3 +$2.94 +46.9% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-27
Q4 2017 -$24 -$5 -$5 -1885% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$19 -$6 -$5 -926% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-29
Q2 2017 -$13 -$6 -$6 -953% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-29
Q1 2017 -$8 -$6 -$6 -747% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-29
Q4 2016 -$2 $0 +$0.46 +63% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-28
Q3 2016 -$3 -$1 +$0.15 +20.8% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-28
Q2 2016 -$3 -$1 +$0.07 +10.4% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-28
Q1 2016 -$3 -$1 +$0.36 +32.7% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-28
Q4 2015 -$3 -$1 +$0.14 +16.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-28
Q3 2015 -$3 -$1 +$0.15 +17.2% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-28
Q2 2015 -$4 -$1 $0 0% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-28
Q1 2015 -$4 -$1 +$0.86 +43.9% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-28
Q4 2014 -$4 -$1 +$12.70 +93.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 -$17 -$1 +$14.90 +94.5% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-10
Q2 2014 -$32 -$1 +$10.20 +93.8% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-10
Q1 2014 -$42 -$2 +$8.71 +81.6% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-10
Q4 2013 -$51 -$14 Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 -$16 Jul 1, 2013 Sep 30, 2013 10-K 2015-03-11
Q2 2013 -$11 Apr 1, 2013 Jun 30, 2013 10-K 2015-03-11
Q1 2013 -$11 Jan 1, 2013 Mar 31, 2013 10-K 2015-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.